Cécile Tardy-Srinivasan (DayOne) and Or Shaked, MD-MPH (Briya) explore how AI can enhance decision-making across the R&D lifecycle, from early research through launch strategy. They discuss how NLP enriches clinical and real-world data, how AI can de-risk protocol design, and how stronger alignment between trial planning and commercial strategy drives greater impact. Watch the recording now, or schedule a personal demo with a Briya expert.